Uterine Leiomyosarcoma clinical trials

Explore recruiting uterine leiomyosarcoma clinical trials.

Recruiting uterine leiomyosarcoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Uterine Leiomyosarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

L-UteCIN : Interest of adjuvant chemotherapy in patients with CINSARC high-risk localized resected uterine leiomyosarcoma

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase III study comparing Trabectedin (T) versus T plus tTF-NGR to entrap T inside the tumor in patients with metastatic and/or refractory soft tissue sarcoma (STS), Acronym: TRABTRAP

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Uterine Leiomyosarcoma trials by city

Uterine Leiomyosarcoma clinical trials

Recruiting uterine leiomyosarcoma studies right now

Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

Letrozole in Uterine Leiomyosarcoma

Also recruiting in Europe

L-UteCIN : Interest of adjuvant chemotherapy in patients with CINSARC high-risk localized resected uterine leiomyosarcoma

Phase III study comparing Trabectedin (T) versus T plus tTF-NGR to entrap T inside the tumor in patients with metastatic and/or refractory soft tissue sarcoma (STS), Acronym: TRABTRAP

Uterine Leiomyosarcoma trials by city

Other conditions